These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 28482782)

  • 1. Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.
    Ranjbari J; Mokhtarzadeh A; Alibakhshi A; Tabarzad M; Hejazi M; Ramezani M
    Curr Pharm Des; 2018 Feb; 23(39):6019-6032. PubMed ID: 28482782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Assembled Nanocarriers Based on Amphiphilic Natural Polymers for Anti- Cancer Drug Delivery Applications.
    Sabra S; Abdelmoneem M; Abdelwakil M; Mabrouk MT; Anwar D; Mohamed R; Khattab S; Bekhit A; Elkhodairy K; Freag M; Elzoghby A
    Curr Pharm Des; 2017; 23(35):5213-5229. PubMed ID: 28552068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery.
    Elzoghby AO; Abd-Elwakil MM; Abd-Elsalam K; Elsayed MT; Hashem Y; Mohamed O
    Curr Pharm Des; 2016; 22(22):3305-23. PubMed ID: 26845323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysaccharide-Based Nanocarriers for Ocular Drug Delivery.
    Formica ML; Calles JA; Palma SD
    Curr Pharm Des; 2015; 21(33):4851-68. PubMed ID: 26290208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent trends in the use of polysaccharides for improved delivery of therapeutic agents: pharmacokinetic and pharmacodynamic perspectives.
    Mehvar R
    Curr Pharm Biotechnol; 2003 Oct; 4(5):283-302. PubMed ID: 14529419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable polymers for targeted delivery of anti-cancer drugs.
    Doppalapudi S; Jain A; Domb AJ; Khan W
    Expert Opin Drug Deliv; 2016 Jun; 13(6):891-909. PubMed ID: 26983898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
    Bayram B; Ozgur A; Tutar L; Tutar Y
    Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supramolecular nanoscale assemblies for cancer diagnosis and therapy.
    Coelho SC; Pereira MC; Juzeniene A; Juzenas P; Coelho MAN
    J Control Release; 2015 Sep; 213():152-167. PubMed ID: 26160308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: A review on recent advances and future challenges.
    Jiang Y; Yan C; Li M; Chen S; Chen Z; Yang L; Luo K
    Int J Biol Macromol; 2024 Oct; 278(Pt 4):135072. PubMed ID: 39191341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Versatile Types of Polysaccharide-Based Drug Delivery Systems: From Strategic Design to Cancer Therapy.
    Sun Y; Jing X; Ma X; Feng Y; Hu H
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric nanoparticles as carrier for targeted and controlled delivery of anticancer agents.
    Taghipour-Sabzevar V; Sharifi T; Moghaddam MM
    Ther Deliv; 2019 Aug; 10(8):527-550. PubMed ID: 31496433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric nanoparticles for targeted drug delivery system for cancer therapy.
    Masood F
    Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():569-578. PubMed ID: 26706565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
    Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
    Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Anionic Polysaccharides in the Preparation of Nanomedicines with Anticancer Applications.
    Martínez AM; Benito M; Pérez E; María Teijón J; Dolores Blanco M
    Curr Pharm Des; 2016; 22(22):3364-79. PubMed ID: 26818877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysaccharides as nanocarriers for therapeutic applications.
    Singh D; Han SS; Shin EJ
    J Biomed Nanotechnol; 2014 Sep; 10(9):2149-72. PubMed ID: 25992452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polysaccharide-modified liposomes and their application in cancer research.
    Peng P; Chen Z; Wang M; Wen B; Deng X
    Chem Biol Drug Des; 2023 Apr; 101(4):998-1011. PubMed ID: 36597375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.